Monte Rosa Therapeutics, Inc. (GLUE) Capital expenditures 2020–2025
Monte Rosa Therapeutics, Inc. (GLUE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.7MFY2025 · since FY2020: $3.4M → $4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.7M | +17.9% |
| FY2024 | $4.0M | -79.1% |
| FY2023 | $19.0M | +47.5% |
| FY2022 | $12.9M | +32.7% |
| FY2021 | $9.7M | +187.2% |
| FY2020 | $3.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice